Ocular Therapeutix (OCUL) announced that Namrata Saroj, OD, has joined the Company on a full-time basis as Chief Business Officer, CBO. Dr. Saroj previously served as Development Strategy Consultant to Ocular since February 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on OCUL:
- OCUL Upcoming Earnings Report: What to Expect?
- Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
- Ocular Therapeutix initiated with an Outperform at Scotiabank
- Ocular Therapeutix management to meet with Piper Sandler
- Ocular announces accelerated timelines for SOL-1 registrational trial
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
